Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CNS
Biotech
CNS biotech attempts to break the IPO ice
The CNS company needs cash badly, with only $14 million in the bank as of June 30, plus an accumulated deficit of $114 million.
Gabrielle Masson
Aug 25, 2025 11:10am
Novartis inks $175M option deal for Sironax’s BBB tech
Jul 9, 2025 10:29am
Julius attaches roots to Peachtree in CRO merger
May 14, 2025 2:52pm
UCB-Novartis Parkinson's asset fails to improve symptoms in ph. 2
Dec 16, 2024 3:19pm
With 4 remaining staffers, CNS-focused Trevena nears end of road
Nov 7, 2024 10:40am
Medidata boosts CNS trials with Cogstate's cognitive assessments
Oct 29, 2024 2:40pm
